Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Conen

Showing results (251-260 of 363) with videos related to

Pageof 37
Sort By:
Journal of Clinical Medicine|December 15, 2020
Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based StudyAnna Schaffner, Lorenz Risch, Stefanie Aeschbacher, et al.
Scientific Reports|February 10, 2022
Long-term risk of adverse outcomes according to atrial fibrillation typeSteffen Blum, Stefanie Aeschbacher, Michael Coslovsky, et al.
Open Heart|April 22, 2021
Heart rate and adverse outcomes in patients with prevalent atrial fibrillationGiorgio Moschovitis, Linda S B Johnson, Steffen Blum, et al.
Journal of Thrombosis and Haemostasis : JTH|January 27, 2021
Novel bleeding risk score for patients with atrial fibrillation on oral anticoagulants, including direct oral anticoagulantsLuise Adam, Martin Feller, Lamprini Syrogiannouli, et al.
The Lancet. Neurology|February 12, 2017
Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AF<sub>RANDOMISED</sub>): an open-label randomised controlled trialRolf Wachter, Klaus Gröschel, Götz Gelbrich, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 28, 2020
Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysisMariëlle Kloosterman, Jonas Oldgren, David Conen, et al.
Swiss Medical Weekly|July 12, 2017
Design of the Swiss Atrial Fibrillation Cohort Study (Swiss-AF): structural brain damage and cognitive decline among patients with atrial fibrillationDavid Conen, Nicolas Rodondi, Andreas Mueller, et al.
Journal of the American College of Cardiology|February 18, 2026
Cardiomyopathy Gene Variants and Polygenic Risk Scores in Atrial Fibrillation: Evidence for an Atrial-First PhenotypeGuilherme L da Rocha, James Feiner, Julieta Lazarte, et al.
Journal of the American Heart Association|August 29, 2025
External Validation of the REACT-HF Score for Predicting Heart Failure in Patients With Atrial FibrillationGiorgio Moschovitis, Elia Rigamonti, Andrea Wiencierz, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 11, 2022
Association of pulmonary vein isolation and major cardiovascular events in patients with atrial fibrillationMarc Girod, Michael Coslovsky, Stefanie Aeschbacher, et al.
Pageof 37

Showing results (251-260 of 363) with videos related to

Sort By:
Pageof 37
Journal of Clinical Medicine|December 15, 2020
Characterization of a Pan-Immunoglobulin Assay Quantifying Antibodies Directed against the Receptor Binding Domain of the SARS-CoV-2 S1-Subunit of the Spike Protein: A Population-Based StudyAnna Schaffner, Lorenz Risch, Stefanie Aeschbacher, et al.
Scientific Reports|February 10, 2022
Long-term risk of adverse outcomes according to atrial fibrillation typeSteffen Blum, Stefanie Aeschbacher, Michael Coslovsky, et al.
Open Heart|April 22, 2021
Heart rate and adverse outcomes in patients with prevalent atrial fibrillationGiorgio Moschovitis, Linda S B Johnson, Steffen Blum, et al.
Journal of Thrombosis and Haemostasis : JTH|January 27, 2021
Novel bleeding risk score for patients with atrial fibrillation on oral anticoagulants, including direct oral anticoagulantsLuise Adam, Martin Feller, Lamprini Syrogiannouli, et al.
The Lancet. Neurology|February 12, 2017
Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AF<sub>RANDOMISED</sub>): an open-label randomised controlled trialRolf Wachter, Klaus Gröschel, Götz Gelbrich, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 28, 2020
Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: an RE-LY AF registry analysisMariëlle Kloosterman, Jonas Oldgren, David Conen, et al.
Swiss Medical Weekly|July 12, 2017
Design of the Swiss Atrial Fibrillation Cohort Study (Swiss-AF): structural brain damage and cognitive decline among patients with atrial fibrillationDavid Conen, Nicolas Rodondi, Andreas Mueller, et al.
Journal of the American College of Cardiology|February 18, 2026
Cardiomyopathy Gene Variants and Polygenic Risk Scores in Atrial Fibrillation: Evidence for an Atrial-First PhenotypeGuilherme L da Rocha, James Feiner, Julieta Lazarte, et al.
Journal of the American Heart Association|August 29, 2025
External Validation of the REACT-HF Score for Predicting Heart Failure in Patients With Atrial FibrillationGiorgio Moschovitis, Elia Rigamonti, Andrea Wiencierz, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 11, 2022
Association of pulmonary vein isolation and major cardiovascular events in patients with atrial fibrillationMarc Girod, Michael Coslovsky, Stefanie Aeschbacher, et al.
Pageof 37